Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermogard
- Development stage
- Unknown
- Lead developer
- Indi Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
**Dermogard** is an Indi Pharma topical antimicrobial/antiseptic brand rather than a single chemically uniform drug product. Public product listings identify at least a cream formulation containing **chlorhexidine gluconate + silver sulfadiazine** for burn and wound infection management, and a liquid formulation containing **cetrimide + chlorhexidine gluconate**. Because the unqualified name encompasses distinct fixed-dose topical formulations with different active ingredients, its precise mechanism and composition cannot be assigned without specifying the dosage form. ([indipharma.com](https://www.indipharma.com/international-2.htm))
- Brand names
- Dermogard
02
Targets
Neuraminidase
Beyond the preview
Go deeper on Dermogard.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermogard.